@article{article, title  = {{LBA29 Nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced renal cell carcinoma: A randomized phase II trial (PRISM)}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2021}},

 month = {{9}},

 author = {{Vasudev NS and Ainsworth G and Brown S and Pickering L and Waddell TS and Fife K and Griffiths R and Sharma A and Katona E and Howard H and Velikova G et al}},

 doi = {{10.1016/j.annonc.2021.08.2105}},

 volume = {{32}},

 journal = {{Annals of Oncology}},

 pages = {{S1304-S1305}},

 note = {{Accessed on 2024/12/27}}}